BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Cell Therapeutics, Inc.’ Highly Selective Oral JAK 2 Inhibitor, Pacritinib, Demonstrates Encouraging Anti-tumor Activity in Patients with Relapsed/Refractory Lymphoma

  September 24, 2012

   · 

  7 min read
• Drug Development

  Zafgen Announces Additional Weight Loss and Cardiometabolic Data from Phase 1b Studies of Beloranib in Obesity at Obesity 2012, the 30th Annual Scientific Meeting of The Obesity Society

  September 24, 2012

   · 

  6 min read
• Business

  Lightlake Therapeutics Inc. Appoints Dr. David Kessler as Strategic Advisor

  September 24, 2012

   · 

  3 min read
• Business

  Savient Pharmaceuticals, Inc. Names John P. Hamill Chief Financial Officer

  September 24, 2012

   · 

  5 min read
• Policy

  Lawsuit Against Centene Corporation Dismissed

  September 24, 2012

   · 

  1 min read
• Business

  Althea Technologies, Inc. Announces Expanded Roles for Key Executives

  September 24, 2012

   · 

  4 min read
• China Botanic Pharmaceutical Inc. (Formerly known as Renhuang Pharmaceuticals Inc.) Schedules Conference Call to Discuss Third Quarter Fiscal Year 2012 Results

  September 24, 2012

   · 

  1 min read
• Policy

  Court Focuses Patent Suit on Santaris Pharma A/S’s Safe Harbor Defense

  September 24, 2012

   · 

  3 min read
• INTEGRA Biosciences AG Release: Extended Length Pipette Tips Improve Labware Access

  September 24, 2012

   · 

  1 min read
• BioMidwest

  Neogen Corporation Announces 1st Quarter Results Conference Call

  September 24, 2012

   · 

  1 min read